Tianxin Pharmaceutical’s public offering on the Shanghai Stock Exchange

Tianxin Pharmaceutical is a vitamin manufacturer, mainly engaged in the research and development and production of vitamin B1, vitamin B6, folic acid and ascorbyl palmitate. The products are widely used in APIs, food additives, feed additives and other fields. FDA certified.

Today, Tianxin Pharmaceutical made a public offering on the Shanghai Stock Exchange.

This article is reprinted from: https://www.itjuzi.com/pre-ipo?comname=%E5%A4%A9%E6%96%B0%E8%8D%AF%E4%B8%9A
This site is for inclusion only, and the copyright belongs to the original author.

Leave a Comment